Vaccination With PD-L1 Peptide Against Multiple Myeloma
Clinical trial NCT03042793 · COMPLETED
Trial details
- NCT number
- NCT03042793
- Sponsor
- Lene Meldgaard Knudsen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2020-05-14
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.